Preliminary Report - ID Mapping
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
covid:unpublished [2020/05/01 16:34] biogridadmin |
covid:unpublished [2020/06/02 13:48] biogridadmin |
||
|---|---|---|---|
| Line 18: | Line 18: | ||
| | **888800000011** | **[[https://doi.org/10.1101/2020.03.16.993386|10.1101/2020.03.16.993386]]** | Gao Y (2020) | **[[https://thebiogrid.org/221198/publication|Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target]]** | | | **888800000011** | **[[https://doi.org/10.1101/2020.03.16.993386|10.1101/2020.03.16.993386]]** | Gao Y (2020) | **[[https://thebiogrid.org/221198/publication|Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target]]** | | ||
| | **888800000012** | **[[https://doi.org/10.1101/2020.03.31.019216|10.1101/2020.03.31.019216]]** | Liang Q (2020) | **[[https://thebiogrid.org/221199/publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** | | | **888800000012** | **[[https://doi.org/10.1101/2020.03.31.019216|10.1101/2020.03.31.019216]]** | Liang Q (2020) | **[[https://thebiogrid.org/221199/publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** | | ||
| - | |||
| | **888800000013** | **[[https://doi.org/10.1101/2020.04.15.042085|10.1101/2020.04.15.042085]]** | Bestle D (2020) | **[[https://thebiogrid.org/221402/publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** | | | **888800000013** | **[[https://doi.org/10.1101/2020.04.15.042085|10.1101/2020.04.15.042085]]** | Bestle D (2020) | **[[https://thebiogrid.org/221402/publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** | | ||
| - | |||
| | **888800000014** | **[[https://doi.org/10.1101/2020.04.09.033233|10.1101/2020.04.09.033233]]** | Jin Z (2020) | **[[https://thebiogrid.org/221403/publication|Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug]]** | | | **888800000014** | **[[https://doi.org/10.1101/2020.04.09.033233|10.1101/2020.04.09.033233]]** | Jin Z (2020) | **[[https://thebiogrid.org/221403/publication|Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug]]** | | ||
| - | |||
| | **888800000015** | **[[https://doi.org/10.1101/2020.04.08.032763|10.1101/2020.04.08.032763]]** | Yin W (2020) | **[[https://thebiogrid.org/221404/publication|Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir]]** | | | **888800000015** | **[[https://doi.org/10.1101/2020.04.08.032763|10.1101/2020.04.08.032763]]** | Yin W (2020) | **[[https://thebiogrid.org/221404/publication|Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir]]** | | ||
| - | |||
| | **888800000016** | **[[https://doi.org/10.1101/2020.04.14.042010|10.1101/2020.04.14.042010]]** | Chi X (2020) | **[[https://thebiogrid.org/221405/publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** | | | **888800000016** | **[[https://doi.org/10.1101/2020.04.14.042010|10.1101/2020.04.14.042010]]** | Chi X (2020) | **[[https://thebiogrid.org/221405/publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** | | ||
| + | | **888800000017** | **[[https://doi.org/10.1101/2020.04.06.20055475|10.1101/2020.04.06.20055475]]** | Ye L (2020) | **[[https://thebiogrid.org/221565/publication|Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor]]** | | ||
| + | | **888800000018** | **[[https://doi.org/10.1101/2020.04.19.049643|10.1101/2020.04.19.049643]]** | Zeng X (2020) | **[[https://thebiogrid.org/221566/publication/blocking-antibodies-against-sars-cov-2-rbd-isolated-from-a-phage-display-antibody-library-using-a-competitive-biopanning-strategy.html]]** | | ||
| + | | **888800000019** | **[[https://doi.org/10.1101/2020.04.23.057265|10.1101/2020.04.23.057265]]** | Peng Q (2020) | **[[https://thebiogrid.org/221567/publication/structural-and-biochemical-characterization-of-nsp12-nsp7-nsp8-core-polymerase-complex-from-covid-19-virus.html]]** | | ||
| + | | **888800000020** | **[[https://doi.org/10.1101/2020.04.22.046565|10.1101/2020.04.22.046565]]** | Liu Y (2020) | **[[https://thebiogrid.org/221568/publication/functional-and-genetic-analysis-of-viral-receptor-ace2-orthologs-reveals-broad-potential-host-range-of-sars-cov-2.html]]** | | ||
| + | | **888800000021** | **[[https://doi.org/10.1101/2020.04.21.053017|10.1101/2020.04.21.053017]]** | Walker A (2020) | **[[https://thebiogrid.org/221569/publication/enisamium-is-a-small-molecule-inhibitor-of-the-influenza-a-virus-and-sars-cov-2-rna-polymerases.html]]** | | ||
| + | | **888800000022** | **[[https://doi.org/10.1101/2020.04.17.047498|10.1101/2020.04.17.047498]]** | Rosas Lemus M (2020) | **[[https://thebiogrid.org/221570/publication/the-crystal-structure-of-nsp10-nsp16-heterodimer-from-sars-cov-2in-complex-with-s-adenosylmethionine.html]]** | | ||
| + | | **888800000023** | **[[https://doi.org/10.1101/2020.04.19.048710|10.1101/2020.04.19.048710]]** | Zhao X (2020) | **[[https://thebiogrid.org/221571/publication/broad-and-differential-animal-ace2-receptor-usage-by-sars-cov-2.html]]** | | ||
| + | | **888800000024** | **[[https://doi.org/10.1101/2020.04.26.061705|10.1101/2020.04.26.061705]]** | Viswanathan T (2020) | **[[https://thebiogrid.org/221642/publication/structural-basis-of-rna-cap-modification-by-sars-cov-2-coronavirus.html]]** | | ||
| + | | **888800000025** | **[[https://doi.org/10.1101/2020.04.29.068890|10.1101/2020.04.29.068890]]** | Rut W (2020) | **[[https://thebiogrid.org/221777/publication/activity-profiling-of-sars-cov-2-plpro-protease-provides-structural-framework-for-anti-covid-19-drug-design.html]]** | | ||
| + | | **888800000026** | **[[https://doi.org/10.1101/2020.04.27.063180|10.1101/2020.04.27.063180]]** | Hillen HS (2020) | **[[https://thebiogrid.org/221778/publication/structure-of-replicating-sars-cov-2-polymerase.html]]** | | ||
| + | | **888800000027** | **[[https://doi.org/10.1101/2020.04.29.068098|10.1101/2020.04.29.068098]]** | Sun Z (2020) | **[[https://thebiogrid.org/221779/publication/mass-spectrometry-analysis-of-newly-emerging-coronavirus-hcov-19-spike-s-protein-and-human-ace2-reveals-camouflaging-glycans-and-unique-post-translational-modifications.html]]** | | ||
| + | | **888800000028** | **[[https://doi.org/10.1101/2020.05.03.073080|10.1101/2020.05.03.073080]]** | Vuong W (2020) | **[[https://thebiogrid.org/221830/publication/feline-coronavirus-drug-inhibits-the-main-protease-of-sars-cov-2-and-blocks-virus-replication.html]]** | | ||
| + | | **888800000029** | **[[https://doi.org/10.1101/2020.05.02.20086876|10.1101/2020.05.02.20086876]]** | Zhang D (2020) | **[[https://thebiogrid.org/221831/publication/ultra-fast-and-onsite-interrogation-of-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-in-environmental-specimens-via-surface-enhanced-raman-scattering-sers.html]]** | | ||
| + | | **888800000030** | **[[https://doi.org/10.1101/2020.05.05.079202|10.1101/2020.05.05.079202]]** | Huo J (2020) | **[[https://thebiogrid.org/221832/publication/neutralization-of-sars-cov-2-by-destruction-of-the-prefusion-spike.html]]** | | ||
| + | | **888800000031** | **[[https://doi.org/10.1101/2020.05.06.079830|10.1101/2020.05.06.079830]]** | Zha L (2020) | **[[https://thebiogrid.org/221833/publication/development-of-a-covid-19-vaccine-based-on-the-receptor-binding-domain-displayed-on-virus-like-particles.html]]** | | ||
| + | | **888800000032** | **[[https://doi.org/10.1101/2020.05.02.043554|10.1101/2020.05.02.043554]]** | Gunther S (2020) | **[[https://thebiogrid.org/221835/publication/catalytic-cleavage-of-heat-and-subsequent-covalent-binding-of-the-tetralone-moiety-by-the-sars-cov-2-main-protease.html]]** | | ||
| + | | **888800000033** | **[[https://doi.org/10.1101/2020.05.01.20077743|10.1101/2020.05.01.20077743]]** | Wu Y (2020) | **[[https://thebiogrid.org/221836/publication/a-non-competing-pair-of-human-neutralizing-antibodies-block-covid-19-virus-binding-to-its-receptor-ace2.html]]** | | ||
| + | | **888800000034** | **[[https://doi.org/10.1101/2020.05.03.074914|10.1101/2020.05.03.074914]]** | Liu X (2020) | **[[https://thebiogrid.org/221959/publication/neutralizing-antibodies-isolated-by-a-site-directed-screening-have-potent-protection-on-sars-cov-2-infection.html]]** | | ||